Sawgrass Asset Management LLC Supernus Pharmaceuticals, Inc. Transaction History

Sawgrass Asset Management LLC

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2018 Nov 19, 2018	SELL	$42.7 - $56.55 $1.69 Million - $2.24 Million	-39,630 Closed	0 $0
Q2 2018 Jul 26, 2018	BUY	$44.1 - $59.85 $1.75 Million - $2.37 Million	39,630 New	39,630 $2.37 Million

283

60.6M

27.7K

11.3K

Ticker SUPN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,495,300
Market Cap $2.11B
Description
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...

Get notified when there are updates to the investment portfolio of Sawgrass Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Sawgrass Asset Management LLC with notifications on news.